NRX Pharmaceuticals Warrant
NRXPW
NRXPW was delisted on the 22nd of May, 2026.
3 hedge funds and large institutions have $2.38K invested in NRX Pharmaceuticals Warrant in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
25% less funds holding
Funds holding: 4 → 3 (-1)
100% less capital invested
Capital invested by funds: $4.46M → $2.38K (-$4.46M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$183 |
| 2 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$51 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BGI
B Group Inc
Dallas,
Texas
|
-$4.46M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$3.07K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WAM
1
Wolverine Asset Management
Chicago,
Illinois
| $1.58K | +$51 | +515 | +2% |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $669 | -$3.07K | -30,755 | -73% |
|
|
3
UBS Group
Zurich,
Switzerland
| $131 | +$183 | +1,834 | +10,189% |
|
|
BGI
4
B Group Inc
Dallas,
Texas
| – | -$4.46M | -3,000,000 | Closed |
|
NRXPW Hedge Fund Activity: Q4 2025 in Review
3 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in NRX Pharmaceuticals Warrant (NRXPW) for Q4 2025, worth a combined $2.38K — down 100% from $4.46M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of NRXPW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 2 added.
The largest buyer was UBS Group, adding an estimated $183. The largest seller was B Group Inc, exiting entirely with an estimated $4.46M sold.
- 3 institutional investors held NRX Pharmaceuticals Warrant (NRXPW) as of Q4 2025, down from 4 in Q3 2025.
- Funds reported $2.38K of NRX Pharmaceuticals Warrant stock for Q4 2025, down 100% quarter-over-quarter.
- 0 funds opened new NRX Pharmaceuticals Warrant positions in Q4 2025 and 1 closed out, a net change of -1 holder.
- The largest NRX Pharmaceuticals Warrant buyer in Q4 2025 was UBS Group, an estimated $183 added.
- The largest NRX Pharmaceuticals Warrant seller in Q4 2025 was B Group Inc, an estimated $4.46M sold.
Based on aggregated 13F filings for Q4 2025.